IFNA1 and neoplasm: In a mice model of PDAC, the combination of TMAO with ICIs significantly reduced tumor load and improved survival; TMAO enhanced the type I interferon (IFN) pathway and conferred antitumor effects in a type I IFN-dependent manner (74).